Tirzepatide is available through prescription and is part of physician-led weight loss protocols
Protein, sleep, hydration, and steps are locked in
This reluctance is likely to be at least partially attributable to the fact that, until recently, all GLP-1RAs were available as subcutaneous (s.c.) injections, given twice daily (exenatide [13]), once daily (lixisenatide [14] and liraglutide [15]), or once weekly (semaglutide [16], dulaglutide [17], and exenatide extended release [18]), a route that may be less preferable to some patients compared with oral administration [1, 19]
Clinical trials consistently show semaglutide, tirzepatide therapy significantly reduces C-reactive protein (CRP) levels compared to placebo or other glucose-lowering medications